U S Physical Therapy Inc (USPH) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
U S Physical Therapy Inc  (NYSE: USPH)

U S Physical Therapy Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for U S Physical Therapy Inc in the second quarter 2026?
U S Physical Therapy Inc achieved a return on average equity (ROE) of 10.5 % in its second quarter 2026, which is below U S Physical Therapy Inc's average return on equity, which stands at 16.03%.

ROE fell compared to the first quarter 2026, despite the net income growth of 82.66% from the first quarter 2026.

Within the Medical Equipment & Supplies industry 37 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 1111 to 1332.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change -10.58 % -5.92 % -2.68 % 4.27 % -
Y / Y Net Income Change -15.93 % -39.44 % -26.56 % 80.44 % 51.3 %
Net Income (TTM) in Millions 50 53 58 61 53
Return On Equity (TTM) 10.5 % 10.79 % 11.7 % 12.29 % 10.82 %
USPH's Total Ranking # 1332 # 1111 # 937 # 807 # 1042
Equity (TTM) in Millions 449 469 477 505 502
Seq. Equity Change -4.32 % -1.56 % -5.53 % 0.5 % 0.67 %
Seq. Net Income Change 82.66 % -11.11 % -47.99 % -0.44 % 31.57 %

Back to USPH Management Effectiveness >> USPH's 5 Years Annual ROE >> Compare USPH ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 38
Sector # 138
Overall # 1332

Return On Equity Statistics
High Average Low
26.18 %
16.03 %
6.6 %
(Jun 30 2019)   (Sep 30 2024)





USPH Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 477 490 477 317 297
Y / Y Equity Change -2.68 % 2.64 % 50.58 % 6.69 % 7.04 %
Net Income in Millions 58 46 37 43 58
Y / Y Net Income Change 27.2 % 22.51 % -14.25 % -25.06 % 10.35 %
Return On Equity 12.16 % 9.31 % 7.8 % 13.69 % 19.49 %

Back to USPH Management Effectiveness >> USPH's 5 Years Annual ROE >> Compare USPH ROE to its Competitors




Annual Roe Comment
In 2025 ROE improved to 12.16 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
USPH's' Return on Equity at Yahoo Finance
USPH's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for USPH's Competitors
Subscribers only: Roe for U S Physical Therapy Inc's Suppliers
Subscribers only: Return On Equity for USPH's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Pacs Group Inc   27.00 %
Sotera Health Company  26.75 %
Insulet Corporation  26.69 %
Bioventus Inc   25.96 %
Johnson and Johnson  25.74 %
Encompass Health Corporation  25.52 %
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %
Electromed Inc   23.65 %
Iradimed Corporation  23.45 %
Vertex Pharmaceuticals Inc  23.31 %
Lantheus Holdings Inc   23.27 %
Msa Safety Inc  23.15 %
Prestige Consumer Healthcare Inc   21.77 %
Jazz Pharmaceuticals Plc  21.37 %
Neurocrine Biosciences Inc   21.13 %
Universal Health Services Inc   20.89 %
Puma Biotechnology Inc   20.85 %
Entera Bio Ltd   20.82 %
United Therapeutics Corporation  20.18 %
Ligand Pharmaceuticals Incorporated  20.06 %
Harmony Biosciences Holdings inc   20.06 %
Pediatrix Medical Group Inc   19.89 %
Theravance Biopharma inc   19.40 %
Krystal Biotech Inc   19.34 %
Ani Pharmaceuticals Inc  19.33 %
Brightspring Health Services Inc   18.93 %
Sbc Medical Group Holdings Incorporated  18.69 %
West Pharmaceutical Services Inc   18.51 %
Intuitive Surgical Inc   17.82 %

Date modified: 2026-09-26T07:12:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.